DSIP

DSIP (Delta Sleep-Inducing Peptide) is a highly characterized nonapeptide recognized for its neuromodulatory properties within the central nervous system. Endogenous to mammals, this peptide was initially identified for its ability to induce delta wave activity in electroencephalograms (EEGs), correlating with slow-wave sleep. As a key agent in neurochemical research, DSIP offers a valuable tool for investigating the complex mechanisms underlying sleep regulation, circadian rhythms, and neurological function.

Our DSIP product is meticulously synthesized to provide researchers with a high-purity reagent for demanding scientific investigations. This peptide is extensively utilized in in vitro and in vivo studies to explore its potential roles in neurotransmitter modulation, stress responses, and its interaction with various brain regions implicated in sleep-wake cycles. Researchers can apply DSIP to probe its influence on physiological processes related to arousal, vigilance, and homeostatic balance, contributing to a deeper understanding of neuropharmacology and brain physiology.

Available as a 10mg vial of lyophilized powder, our DSIP boasts a guaranteed purity of ≥98%, ensuring reliable and reproducible results for your experiments. This research-grade peptide is intended exclusively for scientific research and laboratory applications, providing an essential component for studies in sleep science, neuroscience, and endocrinology. It is not intended for diagnostic, therapeutic, or human consumption.